« Previous Next » European Journal of Cancer
Volume 46, Issue 9 , Pages 1640-1649 , June 2010

The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma

Feng Zhi
- Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- These authors contributed equally to this work.
Xi Chen
- Jiangsu Diabetes Center, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- These authors contributed equally to this work.
Suinuan Wang
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Xiwei Xia
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Yimin Shi
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Wei Guan
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Naiyuan Shao
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Hongtao Qu
- Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Changchun Yang
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Yi Zhang
- Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Qiang Wang
- Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Rong Wang
- Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
Ke Zen
- Jiangsu Diabetes Center, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
Chen-Yu Zhang
- Jiangsu Diabetes Center, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Corresponding authors: Address: Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China. Tel./fax: +86 519 86180899 (Y. Yang).
Junfeng Zhang
- Jiangsu Diabetes Center, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Corresponding authors: Address: Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China. Tel./fax: +86 519 86180899 (Y. Yang).
Yilin Yang
- Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- Department of Neurosurgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China
- Corresponding authors: Address: Research Institute of Modern Medicine, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China. Tel./fax: +86 519 86180899 (Y. Yang).